PHASE-II TRIAL OF CARACEMIDE (NSC-253272) IN ADVANCED UNRESECTABLE NON-SMALL-CELL BRONCHOGENIC-CARCINOMA - AN ILLINOIS CANCER COUNCIL STUDY

被引：7
|
作者：
LAD, T
SCHOR, J
MULLANE, M
CARROLL, R
CHERNICOFF, D
BLOUGH, R
WEIDNER, L
机构：
[1] UNIV ILLINOIS,DEPT MED,MED ONCOL SECT,CHICAGO,IL 60680
[2] W SIDE VET AFFAIRS MED CTR,CHICAGO,IL
[3] CHICAGO OSTEOPATH MED CTR,CHICAGO,IL
来源：
INVESTIGATIONAL NEW DRUGS | 1992年 / 10卷 / 01期
关键词：
PHASE-II; CARACEMIDE; NON-SMALL-CELL LUNG CANCER;
D O I：
10.1007/BF01275475
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [1] PHASE-II TRIAL OF BISANTRENE FOR UNRESECTABLE NON-SMALL CELL BRONCHOGENIC-CARCINOMA - AN ILLINOIS CANCER COUNCIL STUDY
    MCGUIRE, WP
    BLOUGH, RR
    COBLEIGH, MA
    JOHNSON, CM
    KUKLA, LJ
    LAD, TE
    LANZOTTI, VJ
    STIFF, PJ
    ZAWILA, P
    CANCER TREATMENT REPORTS, 1983, 67 (09): : 841 - 842
  • [2] PHASE-II TRIAL OF 4' DEOXYDOXORUBICIN (DXDX) FOR UNRESECTABLE NON-SMALL CELL BRONCHOGENIC-CARCINOMA - AN ILLINOIS-CANCER-COUNCIL STUDY
    ROSE, C
    LAD, TE
    KILTON, LJ
    SCHOR, J
    ROSEN, ST
    ROSSOF, AH
    BLOUGH, RR
    JOHNSON, CM
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (01) : 97 - 99
  • [3] PHASE-II TRIAL OF INTRAVENOUS 6-THIOGUANINE FOR UNRESECTABLE OR METASTATIC NON-SMALL-CELL BRONCHOGENIC-CARCINOMA
    FOSSELLA, FV
    WINN, RJ
    HOLOYE, PY
    RABER, MN
    HOLDEN, L
    BELT, R
    ALLEN, H
    HALLINAN, B
    HARPER, K
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (04) : 375 - 376
  • [4] PHASE-II STUDY OF TIAZOFURIN (NSC-286193) IN THE TREATMENT OF ADVANCED SMALL CELL BRONCHOGENIC-CARCINOMA
    HOLOYE, PY
    CARR, DT
    DHINGRA, HM
    GLISSON, BS
    LEE, JS
    MURPHY, WK
    UMSAWASDI, T
    JEFFRIES, D
    INVESTIGATIONAL NEW DRUGS, 1988, 6 (03) : 217 - 218
  • [5] PHASE-II TRIAL OF TRIMETREXATE FOR UNRESECTABLE OR METASTATIC NONSMALL CELL BRONCHOGENIC-CARCINOMA
    FOSSELLA, FV
    WINN, RJ
    HOLOYE, PY
    HALLINAN, B
    RABER, MN
    HOELZER, K
    YOUNG, JA
    READLING, J
    BOWERS, B
    HONG, WK
    INVESTIGATIONAL NEW DRUGS, 1992, 10 (04) : 331 - 335
  • [6] FINAL EVALUATION OF A PHASE-II STUDY ON THE EFFECT OF EDELFOSINE (AN ETHER LIPID) IN ADVANCED NON-SMALL-CELL BRONCHOGENIC-CARCINOMA
    DRINGS, P
    GUNTHER, I
    GATZEMEIER, U
    ULBRICH, F
    KHANAVKAR, B
    SCHREML, W
    LORENZ, J
    BRUGGER, W
    SCHICK, HD
    VONPAWEL, J
    NORDSTROM, R
    ONKOLOGIE, 1992, 15 (05): : 375 - 382
  • [7] PHASE-II STUDY OF DOXORUBICIN AND MITOMYCIN IN NON-SMALL CELL BRONCHOGENIC-CARCINOMA
    COATES, AS
    FOX, RM
    WOODS, RL
    LEVI, JA
    TATTERSALL, MHN
    CANCER TREATMENT REPORTS, 1982, 66 (01): : 177 - 178
  • [8] PHASE-II TRIAL OF SPIROGERMANIUM IN ADVANCED NON-SMALL CELL LUNG-CANCER - AN ILLINOIS CANCER COUNCIL STUDY
    LAD, TE
    BLOUGH, RR
    EVRARD, M
    SHEVRIN, DP
    COBLEIGH, MA
    JOHNSON, CM
    HANGE, P
    INVESTIGATIONAL NEW DRUGS, 1989, 7 (2-3) : 223 - 224
  • [9] PHASE-II EVALUATION OF VINDESINE IN NON-SMALL CELL BRONCHOGENIC-CARCINOMA
    HUTCHEON, AW
    PALMER, JBD
    PRATT, MA
    CLARK, RA
    CANCER TREATMENT REPORTS, 1983, 67 (11): : 1041 - 1042
  • [10] BENEFITS OF POLYCHEMOTHERAPY IN ADVANCED NON-SMALL-CELL BRONCHOGENIC-CARCINOMA
    CORMIER, Y
    BERGERON, D
    LAFORGE, J
    LAVANDIER, M
    FOURNIER, M
    CHENARD, J
    DESMEULES, M
    CANCER, 1982, 50 (05) : 845 - 849
12345